X0202 SCHEDULE 13D/A 0000950103-25-004492 0000903954 XXXXXXXX LIVE 2 Common Stock, par value $0.01 per share 01/16/2026 false 0001462418 L0175J104 ALTISOURCE PORTFOLIO SOLUTIONS S.A.

33, BOULEVARD PRINCE HENRI L-1724 LUXEMBOURG CITY GRAND DUCHY OF LUXEMBOURG N4 L-1724

Peter C. Gyr 212-713-3123 UBS Asset Management (Americas) LLC 1285 Avenue of the Americas, 11th Floor New York NY 10019 0000903954 N Credit Investments Group, a distinct business unit of UBS Asset Management (Americas) LLC b OO N DE 2689527.00 0.00 2689527.00 0.00 2689527.00 N 23.4 IA Common Stock, par value $0.01 per share ALTISOURCE PORTFOLIO SOLUTIONS S.A. 33, BOULEVARD PRINCE HENRI L-1724 LUXEMBOURG CITY GRAND DUCHY OF LUXEMBOURG N4 L-1724 This Amendment No. 2 (this "Amendment") amends and supplements the statement on Schedule 13D originally filed with the Securities and Exchange Commission (the "SEC") on February 26, 2025 as amended by Amendment No. 1 filed on April 7, 2025 (as amended by this Amendment, the "Schedule 13D") with respect to shares of Common Stock, par value $0.01 per share ("Common Stock"), of the Issuer. Unless indicated otherwise, all items left blank remain unchanged and any items which are reported are deemed to amend and supplement the existing items in the Schedule 13D. Capitalized terms used herein and not otherwise defined in this Amendment shall have the meanings ascribed to them in the Schedule 13D. The business address of the Reporting Person and each Covered Person at UBS Asset Management (Americas) LLC is 1285 Avenue of the Americas, 11th Floor, New York, NY 10019. On January 16, 2026, the Client Accounts sold an aggregate of 2,108 shares of Common Stock (which represents 0.018% of the outstanding shares of Common Stock). The Reporting Person intends to evaluate on an ongoing basis its investment in the Issuer and its options with respect to such investment. Depending on market conditions, an evaluation of the business and the prospect of the Issuer and other factors, the Reporting Person may, in its sole discretion, purchase additional shares of Common Stock, or other securities convertible into or exchangeable for shares of Common Stock, and/or other equity, debt, notes instruments or other securities of the Issuer, dispose of shares of Common Stock or such other securities from time to time in the open market, in privately negotiated transactions or otherwise, and/or otherwise change its intention with respect to any and all matters referred to in this Item 4. Except as set forth herein, the Reporting Person does not have, as of the date of this Schedule 13D, any plans or proposals that relate to or would result in any of the actions or events specified in clauses (a) through (j) of Item 4 of Schedule 13D. However, the Reporting Person reserves the right to adopt such plans or proposals in the future, subject to applicable regulatory requirements, if any. The Client Accounts are the direct holders of an aggregate of 2,689,527 shares of Common Stock, constituting approximately 23.4% of the outstanding Common Stock, including Cash Exercise Warrants exercisable for 112,133 shares of Common Stock and Cashless Exercise Warrants exercisable for 112,133 shares of Common Stock. The foregoing percentage is calculated based on 11,278,949 shares of Common Stock outstanding as of April 17, 2026 (as reported by the Issuer in the Quarterly Report on Form 10-Q filed with the SEC on April 23, 2026) and an aggregate of 224,266 shares of Common Stock issuable upon exercise of the Warrants. For purposes of the calculations in this Schedule 13D, we have assumed that all of the shares of Common Stock underlying the Cashless Exercise Warrants are beneficially owned; however, the number of shares of Common Stock issuable upon the exercise of Cashless Exercise Warrants will depend on the price of the Common Stock at the time of exercise, and fewer than all of the shares of Common Stock underlying the Cash Exercise Warrants will be issued upon any exercise thereof. The information as to the number of shares of Common Stock (and shares issuable upon exercise of the Warrants) in this Amendment have been retroactively adjusted to give effect to a 1-for-8 reverse stock split of the Common Stock, effective as of May 28, 2025. See rows (7) through (10) of the cover page to this Schedule 13D, which are incorporated herein by reference. The Client Accounts have not engaged in any transactions in shares of Common Stock during the past sixty days. Except for the Client Accounts which are the direct holders of the Shares, no other person is known by the Reporting Person to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any shares of Common Stock that may be beneficially owned by the Reporting Person. Not Applicable. Item 6 of the Schedule 13D is hereby supplemented by incorporating by reference in its entirety the information set forth in Item 4 above. Credit Investments Group, a distinct business unit of UBS Asset Management (Americas) LLC /s/ Peter C. Gyr 05/21/2026